Obesity drug Wegovy's landmark trial result could 'open up' health insurance access, analyst says

Popular weight-loss drug Wegovy could be made available under more health insurance schemes after the results of a late-stage trial pointed to the drug's efficacy in reducing cardiovascular events, analysts said Wednesday.

from Health and Science https://ift.tt/hCsDPSk
https://ift.tt/c2yfDE6
https://ift.tt/lPoaIEq